Thyroid carcinoma following treatment for acute lymphoblastic leukemia.
A 2 1/2-year-old girl with acute lymphoblastic leukemia received chemotherapy and prophylactic cranial irradiation. After six years of remission, including three years off therapy, metastatic thyroid carcinoma appeared in the cervical lymph nodes. The predisposing factors for the development of thyroid carcinoma as a second malignancy in this case are discussed. It is suggested that thyroid carcinoma should be added to the growing list of second malignancies in acute lymphoblastic leukemia and that careful thyroid examination be included in the follow-up of long-term survivors.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002277:Carcinoma / Q000150:complications* / Q000648:ultrastructure; D002675:Child, Preschool; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000628:therapy; D009381:Neoplasms, Radiation-Induced / Q000648:ultrastructure; D011878:Radiotherapy / Q000009:adverse effects; D012306:Risk; D013964:Thyroid Neoplasms / Q000150:complications* / Q000648:ultrastructure
D000970:Antineoplastic Agents